Ureshino H, Takahashi N, Ikezoe T, Kameoka Y, et al. A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial). Int J Hematol 2024 Aug 13. doi: 10.1007/s12185-024-03830.
PMID: 39136895